You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Claims for Patent: 11,291,740

✉ Email this page to a colleague

Summary for Patent: 11,291,740

Title:	Fogging system and methods for enclosed chambers
Abstract:	A system for disinfecting an enclosed chamber may include a housing, an inlet and an outlet carried by the housing to be connected in a closed airflow path with the enclosed chamber. A dehumidification chamber, a blower, and an evaporation chamber may be carried by the housing and connected in the airflow path between the inlet and outlet. An atomizing nozzle may be positioned within the evaporation chamber and connected to a disinfectant fluid reservoir and an air compressor and configured to atomize disinfectant within the evaporation chamber. An airflow valve may be connected in the airflow path, and a controller may be configured to, during a treatment phase, operate the compressor to introduce atomized disinfectant into the airflow path, and during an evacuation phase, operate the airflow valve to divert the airflow path through the desiccation chamber to remove atomized disinfectant from the airflow path.
Inventor(s):	Steven T. Grinstead, Corwin A Warner
Assignee:	GCMG Companies LLC
Application Number:	US16/991,180

Details for Patent 11,291,740

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Glaxosmithkline Biologicals	SHINGRIX	zoster vaccine recombinant, adjuvanted	Injection	125614	October 20, 2017	⤷ Get Started Free	2040-08-12
Glaxosmithkline Biologicals	SHINGRIX	zoster vaccine recombinant, adjuvanted	For Injection	125614	July 23, 2021	⤷ Get Started Free	2040-08-12
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,291,740

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
United States of America	2024066166	⤷ Get Started Free
United States of America	2022226524	⤷ Get Started Free
United States of America	2021046204	⤷ Get Started Free
United States of America	11819586	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.